Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Alzheimer's Disease Pathology in a Large Norwegian Population-based Cohort and Predictive Power of Plasma p-tau217 and NfL.

NCT06719453 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT06719453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06719453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Alzheimer's Disease Pathology in a Large Norwegian Population-based Cohort and Predictive Power of Plasma p-tau217 and NfL.
Lead sponsor
Helse Stavanger HF
Phase
Observational
Overall status
Completed
Start date
October 3, 2006
Completion date
October 21, 2024
Enrollment
9,663 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, biomarker in early diagnosis, dementia of alzheimer type, mild cognitive impairment, pathology